Anne-Virginie Eggimann
Director/Board Member presso CODIAK BIOSCIENCES
Profilo
Anne-Virginie Eggimann is on the board of Codiak BioSciences, Inc. and Chief Regulatory Officer at bluebird bio, Inc.
He received a graduate degree from the University of California, Los Angeles and an undergraduate degree from California Institute of Technology.
Posizioni attive di Anne-Virginie Eggimann
Società | Posizione | Inizio |
---|---|---|
BLUEBIRD BIO, INC. | Corporate Officer/Principal | 01/09/2011 |
CODIAK BIOSCIENCES | Director/Board Member | 17/05/2021 |
Precedenti posizioni note di Anne-Virginie Eggimann
Società | Posizione | Fine |
---|---|---|
Voisin Consulting, Inc.
Voisin Consulting, Inc. Miscellaneous Commercial ServicesCommercial Services Voisin Consulting, Inc. provides product development consulting services. It guides biotechnology, pharmaceutical and medical technology manufacturers throughout product development and commercialization. The company was founded by Emanuelle M. Viosin in 1997 and is headquartered in Cambridge, MA. | Director/Board Member | - |
Formazione di Anne-Virginie Eggimann
University of California, Los Angeles | Graduate Degree |
California Institute of Technology | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 1 |
---|---|
BLUEBIRD BIO, INC. | Health Technology |
Aziende private | 2 |
---|---|
Voisin Consulting, Inc.
Voisin Consulting, Inc. Miscellaneous Commercial ServicesCommercial Services Voisin Consulting, Inc. provides product development consulting services. It guides biotechnology, pharmaceutical and medical technology manufacturers throughout product development and commercialization. The company was founded by Emanuelle M. Viosin in 1997 and is headquartered in Cambridge, MA. | Commercial Services |
Codiak BioSciences, Inc.
Codiak BioSciences, Inc. Pharmaceuticals: MajorHealth Technology Codiak BioSciences, Inc. engages in the development and manufacturing of exosomes. It engages in harnessing exosomes, therapeutic applications, diagnostic applications, and proprietary production. The firm develops engEx Platform, a proprietary and versatile exosome engineering and manufacturing platform, to expand upon the innate properties of exosomes to design novel exosome therapeutics. Codiak BioSciences was founded by Douglas E. William, Raghu Kalluri, and Eric S. Lander in 2015 and is headquartered in Cambridge, MA. | Health Technology |